Collagen Solutions PLC (LON:COS)‘s stock had its “buy” rating restated by investment analysts at Panmure Gordon in a note issued to investors on Thursday.

Separately, Beaufort Securities restated a “buy” rating on shares of Collagen Solutions PLC in a research report on Tuesday, July 12th.

Shares of Collagen Solutions PLC (LON:COS) opened at 7.84 on Thursday. Collagen Solutions PLC has a 52 week low of GBX 5.00 and a 52 week high of GBX 11.12. The company’s market capitalization is GBX 13.44 million. The stock has a 50 day moving average price of GBX 8.27 and a 200-day moving average price of GBX 7.27.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Collagen Solutions PLC Company Profile

Collagen Solutions plc is a United Kingdom-based holding company. The Company is engaged in supply, development and manufacture of medical grade collagen components and bio materials for use in regenerative medicine, medical devices and in-vitro diagnostics. The Company’s products include CS001, which is a type I Bovine soluble collagen; CS004, which is a type I Acid swollen gel; CS007, which is a titration buffer; CS010, which is a Bovine Dermal fibrous powder; CS013, which is a type I fibrous powder; CS019, which is a type I Bovine soluble collagen; CS022, which is a pulp, and CS028, which is a type I acid soluble collagen.

Receive News & Ratings for Collagen Solutions PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Collagen Solutions PLC and related companies with's FREE daily email newsletter.